Literature DB >> 11491194

The RAND-36 measure of health-related quality of life.

R D Hays1, L S Morales.   

Abstract

The RAND-36 is perhaps the most widely used health-related quality of life (HRQoL) survey instrument in the world today. It is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Physical and mental health summary scores are also derived from the eight RAND-36 scales. This paper provides example applications of the RAND-36 cross-sectionally and longitudinally, provides information on what a clinically important difference is for the RAND-36 scales, and provides guidance for summarizing the RAND-36 in a single number. The paper also discusses the availability of the RAND-36 in multiple languages and summarizes changes that are incorporated in the latest version of the survey.

Entities:  

Mesh:

Year:  2001        PMID: 11491194     DOI: 10.3109/07853890109002089

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  376 in total

1.  Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes.

Authors:  Samuel M Brown; Emily L Wilson; Angela P Presson; Victor D Dinglas; Tom Greene; Ramona O Hopkins; Dale M Needham
Journal:  Thorax       Date:  2017-08-04       Impact factor: 9.139

2.  Sex differences in pain and misuse of prescription analgesics among persons with HIV.

Authors:  Jennie C I Tsao; Judith A Stein; Aram Dobalian
Journal:  Pain Med       Date:  2010-04-29       Impact factor: 3.750

3.  Differential reports of pain and depression differentiate mild cognitive impairment from cognitively intact elderly participants.

Authors:  T M Kruger; E L Abner; M Mendiondo; F A Schmitt; C D Smith; G A Jicha
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-06       Impact factor: 2.680

4.  Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) in patients with drug and alcohol use disorders.

Authors:  Shannon Byrne; Nancy M Petry
Journal:  AIDS Care       Date:  2012-05-30

Review 5.  Scoring the SF-36 in Orthopaedics: A Brief Guide.

Authors:  Nicholas C Laucis; Ron D Hays; Timothy Bhattacharyya
Journal:  J Bone Joint Surg Am       Date:  2015-10-07       Impact factor: 5.284

6.  Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Authors:  George A Kaysen; Brett Larive; Patricia Painter; Alexander Craig; Robert M Lindsay; Michael V Rocco; John T Daugirdas; Gerald Schulman; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

7.  EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36.

Authors:  A Nordlund; K Ekberg; M Kristenson
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

8.  Construct validity of the SF-12 among American Indian and Alaska Native people using two known scoring methods.

Authors:  Sandra L Edwards; Molly McFadden; Anne P Lanier; Maureen A Murtaugh; Elizabeth D Ferucci; Diana G Redwood; Lillian Tom-Orme; Martha L Slattery
Journal:  J Health Care Poor Underserved       Date:  2012-08

9.  Weight change and health related quality of life: population-based longitudinal study of the effects of health related quality of life on the success of weight management.

Authors:  Tellervo Seppälä; Pekka Mäntyselkä; Ulla Saxen; Hannu Kautiainen; Salme Järvenpää; Päivi E Korhonen
Journal:  J Community Health       Date:  2014-04

10.  Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals.

Authors:  Jessica Ng; Robert S Sheldon; Debbie Ritchie; Vidya Raj; Satish R Raj
Journal:  Pacing Clin Electrophysiol       Date:  2018-12-10       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.